- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €906EUR$950USD£774GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €906EUR$950USD£774GBP
The Lithium Test is a point-of-care diagnostic test used to measure the level of lithium in the blood. It is used to monitor the effectiveness of lithium therapy in patients with bipolar disorder, as well as to detect lithium toxicity. The test is typically performed in a doctor's office or clinic, and results are available within minutes. The test is also used to monitor lithium levels in patients who are taking lithium as a medication.
The Lithium Test market is a rapidly growing segment of the point-of-care diagnostics industry. It is driven by the increasing prevalence of bipolar disorder, as well as the need for more accurate and timely diagnosis and monitoring of lithium levels. The market is expected to continue to grow as more healthcare providers adopt point-of-care diagnostics.
Some companies in the Lithium Test market include Abbott, Roche, Siemens, and Alere. Show Less Read more